Fennec Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FENC and other ETFs, options, and stocks.

About FENC

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. 

CEO
Rostislav C. Raykov
CEORostislav C. Raykov
Employees
10
Employees10
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
1996
Founded1996
Employees
10
Employees10

FENC Key Statistics

Market cap
258.32M
Market cap258.32M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
112.82K
Average volume112.82K
High today
High today
Low today
Low today
Open price
$9.75
Open price$9.75
Volume
0.00
Volume0.00
52 Week high
$9.96
52 Week high$9.96
52 Week low
$3.82
52 Week low$3.82

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

FENC Earnings

-$0.31
$0.04
$0.40
$0.75
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 28, Pre-Market
ActualExpected Feb 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.